These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


151 related items for PubMed ID: 22939870

  • 1. The CXCL12 G801A polymorphism and cancer risk: evidence from 17 case-control studies.
    Gong H, Tan M, Wang Y, Shen B, Liu Z, Zhang F, Liu Y, Qiu J, Bao E, Fan Y.
    Gene; 2012 Nov 10; 509(2):228-31. PubMed ID: 22939870
    [Abstract] [Full Text] [Related]

  • 2. The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis.
    Wang J, Ding Q, Shi Y, Cao Q, Qin C, Zhu J, Chen J, Yin C.
    Mutagenesis; 2012 May 10; 27(3):305-12. PubMed ID: 22058059
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. CXCL12 G801A polymorphism and breast cancer risk: a meta-analysis.
    Shen W, Cao X, Xi L, Deng L.
    Mol Biol Rep; 2012 Feb 10; 39(2):2039-44. PubMed ID: 21643956
    [Abstract] [Full Text] [Related]

  • 7. The Cox-2 -1195 G > A polymorphism and cancer risk: a meta-analysis of 25 case-control studies.
    Tang Z, Nie ZL, Pan Y, Zhang L, Gao L, Zhang Q, Qu L, He B, Song G, Zhang Y, Shukui Wang.
    Mutagenesis; 2011 Nov 10; 26(6):729-34. PubMed ID: 21734230
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CXCL12 G801A polymorphism and cancer risk: An updated meta-analysis.
    Meng D, Wu YX, Heerah V, Peng S, Chu MD, Xu YJ, Xiong WN, Xu SY.
    J Huazhong Univ Sci Technolog Med Sci; 2015 Jun 10; 35(3):319-326. PubMed ID: 26072067
    [Abstract] [Full Text] [Related]

  • 14. P53 codon 72 polymorphism contributes to breast cancer risk: a meta-analysis based on 39 case-control studies.
    Zhang Z, Wang M, Wu D, Wang M, Tong N, Tian Y, Zhang Z.
    Breast Cancer Res Treat; 2010 Apr 10; 120(2):509-17. PubMed ID: 19629678
    [Abstract] [Full Text] [Related]

  • 15. Myeloperoxidase G-463A polymorphism and susceptibility to coronary artery disease: a meta-analysis.
    Tang N, Wang Y, Mei Q.
    Gene; 2013 Jul 10; 523(2):152-7. PubMed ID: 23583798
    [Abstract] [Full Text] [Related]

  • 16. SDF-1alpha G801A polymorphism predicts lymph node metastasis in stage T3 colorectal cancer.
    Chang SC, Lin PC, Yang SH, Wang HS, Li AF, Lin JK.
    Ann Surg Oncol; 2009 Aug 10; 16(8):2323-30. PubMed ID: 19472013
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Association between polymorphisms in interleukin-4Rα and interleukin-13 and glioma risk: a meta-analysis.
    Sun G, Wang X, Shi L, Yue X, Fu L, Chen C, Li Z, Pan T, Wan Z.
    Cancer Epidemiol; 2013 Jun 10; 37(3):306-10. PubMed ID: 23395224
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.